Official Show Preview

Daga Global Chemicals, an ISO-certiﬁ ed trading ﬁ rm, is Senn Chemicals is a Swiss chemistry outsourcing partner for
headquartered in India with marketing ofﬁ ces in Dubai and China. clients in the pharmaceutical, biotechnology, cosmetic and
It exports APIs, intermediates, pellets and ﬁ nished dosage forms, diagnostic industries. It has expertise in the manufacture of diverse
as well as bulk and ﬁ ne chemicals to more than 17 countries in molecular classes, such as peptides, carbohydrates, chiral organic
Asia, Middle East and Africa. compounds and functionalised polymers, and offers a seamless
portfolio of solutions from early-stage discovery to large-scale
Orffa Pharma is a Dutch ﬁ rm, based in Werkendam, with an
GMP manufacturing of intermediates and APIs.
interest in APIs and intermediates. Also present will be Hangzhou
Zhongmei Huadong Pharmaceutical, a provider of multiple Germany’s Lohmann Therapie-Systeme provides customised
services to pharmaceutical customers. therapeutic transdermal and oral thin ﬁ lm products and services,
from formulation development and scale-up to commercial
Amega Biotech is an umbrella organisation based in Argentina
manufacturing, including clinical services. It has FDA- and EMEA-
that supports independent structures for the production of
registered production facilities in the US, as well as in Germany.
biosimilars. Amega says this allows a fully controlled process from
raw material (API) to the ﬁ nished product. It boasts an in-house Italy’s Haemopharm group manufactures and distributes
developed biogeneric protein: PEG G-CSF. empty bags for all pharmaceutical applications, parenteral and
other sterile solutions for therapies and special applications. It
Chemwerth, a full service generic development and supply
also provides feasibility studies, special projects for tailor-made
company, is a supplier of APIs to regulated markets worldwide.
products and packaging.
The ﬁ rm provides expertise in R&D; technical and regulatory
services; sales and marketing; and project management. Spain’s Esteve Quimica has six cGMP plants (including
clean room facilities for injectable grade products), with a
And further extending its APIs portfolio, BASF has launched
total capacity in excess of 1,000 cu m. In June, the company
phenylephrine, a pseudoephedrine substitute. With Ibuprofen
inaugurated its newest plant in China (150 cu m). Its facilities
DC85, a more robust Ibuprofen formulation, and the
in Spain have invested in spray-dry technology. Portugal’s
environmentally friendly NanoSelect catalysts, BASF says it offers
BluePharma holds dossiers for azithromycin, acarbose,
valuable solutions to its customers.
clarithromycin, candesartan/hydrochlorothiazide, candesartan,
Contract manufacturing
losartan, losartan/hydrochlorothiazide and ramipril. It
Ash Stevens of the US offers services that include process
also holds dossiers for aripiprazole, irbesartan, irbesartan/
hydrochlorothiazide, levetiracetan, pramipexole and propiverine
8
development, comprehensive analytical and regulatory support
for all phases of drug development and manufacturing, early-
under development.
stage development to commercial cGMP/API manufacturing, SAS Pierre Fabre Médicament Production specialises in active
and the manufacture of highly potent APIs using glove box ingredients and the manufacturing of: liquid and freeze-dried
technology. injectables, anticancer drugs and biotech products; lozenges; and
Another US ﬁ rm, PharmaCore, is adding a new 16,000 sq ft pilot
dry forms such as tablets, capsules, creams, liquids and tooth
plant to its existing facility in North Carolina. Laboratory and kilo-
pastes. The company offers a full service in the development,
scale cGMP capacity have been augmented with the addition of
clinical evaluation and stability testing of batches and scale-up to
several new synthesis suites with reactor sizes up to 2,000 litres.
commercial amounts.
Pfi zer CentreSource offers worldwide expertise and capacity
Wockhardt UK is a global contract manufacturer whose ﬂ exible,
in ﬁ ne chemicals and ﬁ nished dosage form manufacturing. Its
end-to-end service is redeﬁ ning manufacturing for a range of
fully accredited worldwide manufacturing network is supported
sterile injectables, including cartridges and lyophilisation, as well as
by dedicated project teams, an excellent record of regulatory
other conventional dosage forms.
compliance, and a history of innovation and long-term LGV Capsules, based in France, offers contract manufacture of
investment. pharmaceutical forms; primary and secondary packaging; cosmetic
Latvia-based Grindeks offers high-quality, customised product
products; R&D and other services.
development and contract manufacturing. The company’s scale- Meanwhile, Jiangxi Kingnord Industrial, based in Nanchang,
up laboratory provides the opportunity for new or niche product China, says it has the only FDA-inspected multipurpose facility
research and manufacturing in small batches, while ﬁ nal dosage in the country. Its main business is custom manufacture of
forms manufacturing is performed in a brand new plant, applying intermediates including GMP advanced intermediates in lots
global level technologies and complying with GMP and ISO ranging from grams to tonnes.
standards.
Patheon is a provider of contract development and
Piramal Healthcare, based in the UK, manufactures and manufacturing services. Patheon provides products and services to
packages Phase I-III clinical trial materials through to commercial more than 300 of the world’s leading pharmaceutical and biotech
volumes for API and solid dosage drug product companies. companies.
Scrip World Pharmaceutical News Supplement August 2009
cphi.com | icsexpo.com | p-mec.com | bioph-online.com
wherepharmameets.com | scripnews.com
Page 1 | Page 2 | Page 3 | Page 4 | Page 5 | Page 6 | Page 7 | Page 8 | Page 9 | Page 10 | Page 11 | Page 12 | Page 13 | Page 14 | Page 15 | Page 16 | Page 17 | Page 18 | Page 19 | Page 20 | Page 21 | Page 22 | Page 23 | Page 24 | Page 25 | Page 26 | Page 27 | Page 28 | Page 29 | Page 30 | Page 31 | Page 32 | Page 33 | Page 34 | Page 35 | Page 36 | Page 37 | Page 38 | Page 39 | Page 40 | Page 41 | Page 42 | Page 43 | Page 44